These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 30607149)

  • 1. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.
    Emami L; Hassani M; Mardaneh P; Zare F; Saeedi M; Emami M; Khabnadideh S; Sadeghian S
    BMC Chem; 2024 Jul; 18(1):125. PubMed ID: 38965630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer
    Faizan S; Talath S; Wali AF; Hani U; Haider N; Mandal SP; Kumar BRP
    RSC Adv; 2024 Apr; 14(16):11368-11387. PubMed ID: 38595721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors.
    Shihab WA; Kubba AAR; Tahtamouni LH; Saleh KM; AlSakhen MF; Kanaan SI; Saleh AM; Yasin SR
    Curr Med Chem; 2024 Apr; ():. PubMed ID: 38693732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity.
    Li C; Xu F; Zhao Y; Zheng W; Zeng W; Luo Q; Wang Z; Wu K; Du J; Wang F
    Front Chem; 2020; 8():210. PubMed ID: 32411653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based virtual screening of anticanerous polyphenolic phytocompounds against G-protein coupled receptor and identification of potent antagonist ligand(s) through molecular docking.
    Pitchai D; Manikkam R; V SL; Singaram R
    Bioinformation; 2011; 6(6):226-8. PubMed ID: 21738320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents.
    Mahto MK; Yellapu NK; Kilaru RB; Chamarthi NR; Bhaskar M
    Bioinformation; 2014; 10(4):221-6. PubMed ID: 24966524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer.
    Sait KHW; Alam Q; Anfinan N; Al-Ghamdi O; Malik A; Noor R; Jahan F; Tarique M
    Bioinformation; 2019; 15(4):287-294. PubMed ID: 31285646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of mutation on neurotoxicity reduction of new chimeric reteplase, a computational study.
    Pour PM; Mahnam K; Taherzadeh M; Ahangarzadeh S; Alibakhshi A; Mohammadi E
    Res Pharm Sci; 2023; 18(4):404-412. PubMed ID: 37614611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinspired thiazolo-[2,3-b] quinazolin-6-one derivatives as potent anti-cancer agents targeting EGFR: their biological evaluations and in silico assessment.
    Mir SA; Mohanta PP; Meher RK; Baitharu I; Behera AK; Raut S; Nayak B
    Mol Divers; 2023 Jul; ():. PubMed ID: 37395840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Prediction of Resistance Induced Alanine-Mutation in ATP Site of Epidermal Growth Factor Receptor.
    Amelia T; Setiawan AN; Kartasasmita RE; Ohwada T; Tjahjono DH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses.
    S L; A S; Dv S; Bs R; R S; Sharaf S; Sa A; G R
    Curr Res Pharmacol Drug Discov; 2022; 3():100080. PubMed ID: 35059624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents.
    Malekzadeh M; Dadkhah S; Khodarahmi GA; Asadi P; Hassanzadeh F; Rostami M
    Res Pharm Sci; 2022 Feb; 17(1):22-34. PubMed ID: 34909041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2.
    Sangande F; Julianti E; Tjahjono DH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Approaches in Preclinical Studies on Drug Discovery and Development.
    Wu F; Zhou Y; Li L; Shen X; Chen G; Wang X; Liang X; Tan M; Huang Z
    Front Chem; 2020; 8():726. PubMed ID: 33062633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of
    Nasab RR; Mansourian M; Hassanzadeh F; Shahlaei M
    Res Pharm Sci; 2018 Dec; 13(6):509-522. PubMed ID: 30607149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Molecular Dynamics Simulation, and
    Nili Ahmadabadi M; Rezaee E; Nematpour M; Karami L; Mokhtari S; Kobarfard F; Tabatabai SA
    Iran J Pharm Res; 2022 Dec; 21(1):e133840. PubMed ID: 36915409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel JAK2 and EGFR inhibitors from a series of thiazole-based chalcone derivatives.
    Sanachai K; Aiebchun T; Mahalapbutr P; Seetaha S; Tabtimmai L; Maitarad P; Xenikakis I; Geronikaki A; Choowongkomon K; Rungrotmongkol T
    RSC Med Chem; 2021 Mar; 12(3):430-438. PubMed ID: 34046625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.
    Lü S; Zheng W; Ji L; Luo Q; Hao X; Li X; Wang F
    Eur J Med Chem; 2013 Mar; 61():84-94. PubMed ID: 22867529
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.